We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vanda Receives FDA Approval for Atypical Antipsychotic
Vanda Receives FDA Approval for Atypical Antipsychotic
May 7, 2009
The FDA has approved Vanda Pharmaceuticals’ atypical antipsychotic Fanapt for the acute treatment of adult patients with schizophrenia.